Cell signaling by protein carbonylation and decarbonylation

Antioxidants and Redox Signaling

Volumn 12, Issue 3, 2010, Pages 393-404

  Wong, Chi Ming ^a   Marcocci, Lucia ^b   Liu, Lingling ^a   Suzuki, Yuichiro J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; LIPOCORTIN 1; PLATELET DERIVED GROWTH FACTOR; PROTEIN; REACTIVE OXYGEN METABOLITE; SEROTONIN;

AIRWAY; CELL COMMUNICATION; CELL GROWTH; FENTON REACTION; HEART MUSCLE CELL; HUMAN; LUNG CIRCULATION; MAMMAL CELL; MASS SPECTROMETRY; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CARBONYLATION; PROTEIN DECARBONYLATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PULMONARY ARTERY; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SYSTEMIC CIRCULATION;

ANIMALS; ANNEXIN A1; ENDOTHELIN-1; HUMANS; MODELS, BIOLOGICAL; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 75149170936     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2805     Document Type: Review

References (80)

1. Alldridge LC and Bryant CE. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1=2 MAPK signal. Exp Cell Res 290: 93-107, 2003.
2. Amici A, Levine RL, Tsai L, and Stadtman ER. Conversion of amino acid residues in proteins and amino acid homopoly-mers to carbonyl derivatives by metal-catalyzed oxidation reactions. J Biol Chem 264: 3341-3346, 1989.
3. Barreiro E, Gea J, Di Falco M, Kriazhev L, James S, and Hussain SN. Protein carbonyl formation in the diaphragm. Am J Respir Cell Mol Biol 32: 9-17, 2005.
4. Bianchi P, Kunduzova O, Masini E, Cambon C, Bani D, Raimondi L, Seguelas MH, Nistri S, Colucci W, Leducq N, and Parini A. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 112: 3297-3305, 2005.
5. Bianchi P, Pimentel DR, Murphy MP, Colucci WS, and Parini A. A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation. FASEB J 19: 641-643, 2005.
6. Blackwell GJ, Carnuccio R, Di Rosa M, Flower RJ, Parente L, and Persico P. Macrocortin: A polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 287: 147-149, 1980.
7. Boyd-Kimball D, Sultana R, Poon HF, Lynn BC, Casamenti F, Pepeu G, Klein JB, and Butterfield DA. Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: Implications for Alzheimer's disease. Neuroscience 132: 313-324, 2005.
8. Cai H, Griendling KK, and Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24: 471-478, 2003.
9. Canaider S, Solito E, de Coupade C, Flower RJ, Russo-Marie F, Goulding NJ, and Perretti M. Increased apoptosis in U937 cells over-expressing lipocortin 1 (annexin I). Life Sci 66: 265-270, 2000.
10. Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, and Rubin LJ. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study. Lancet 358:1119-1123, 2001. (Pubitemid 32971843)
11. Chanrion B, Mannoury la Cour C, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan MJ, Bockaert J, and Marin P. Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci USA 104: 8119-8124, 2007.
12. Czech MP, Lawrence JC Jr, and Lynn WS. Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc Natl Acad Sci USA 71: 4173-4177, 1974.
13. D'Autreaux B and Toledano MB. ROS as signaling molecules: Mechanisms that generate specificity in ROS homeo-stasis. Nature Rev Mol Cell Biol 8: 813-824, 2007.
14. Davie N, Haleen SJ, Upton PD, Polak JM, Yacoub MH, Morrell NW, and Wharton J. ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 165: 398-405, 2002.
15. Debret R, El Btaouri H, Duca L, Rahman I, Radke S, Haye B, Sallenave JM, and Antonicelli F. Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells. FEBS Lett 546: 195-202, 2003.
16. Dalle-Donne I, Carini M, Orioli M, Vistoli G, Regazzoni L, Colombo G, Rossi R, Milzani A, Aldini G. Protein carbonyla-tion: 2,4-dinitrophenylhydrazine reacts with both aldehydes= ketones and sulfenic acids. Free Radic Biol Med 46: 1411-1419, 2009.
17. Eddahibi S, Raffestin B, Pham I, Launay JM, Aegerter P, Sitbon M, and Adnot S. Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Am J Physiol 272: H1173-H1181, 1997.
18. Eddahibi S, Hanoun N, Lanfumey L, Lesch KP, Raffestin B, Hamon M, and Adnot S. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 105: 1555-1562, 2000.
19. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, and Adnot S. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 198: 1141-1150, 2001.
20. Förstermann U and Münzel T. Endothelial nitric oxide synthase in vascular disease: From marvel to menace. Circulation 113: 1708-1714, 2006.
21. Gerschman R, Gilbert DL, Nye SW, Dwyer P, and Fenn WO. Oxygen poisoning and x-irradiation: A mechanism in common. Science 119: 623-626, 1954.
22. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994.
23. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
24. Grimsrud PA, Xie H, Griffin TJ, and Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 283: 21837-21841, 2008.
25. Grune T, Reinheckel T, and Davies KJ. Degradation of oxidized proteins in mammalian cells. FASEB J 11: 526-534, 1997.
26. Guilluy C, Rolli-Derkinderen M, Tharaux PL, Melino G, Pacaud P, and Loirand G. Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J Biol Chem 282: 918-2928, 2007.
27. Halliwell B and Gutteridge J. Free Radicals in Biology and Medicine. Oxford University Press, 1985.
28. Hassoun PM, Thappa V, Landman MJ, and Fanburg BL. Endothelin 1: Mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med 199: 165-170, 1992.
29. Herve P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, and Drouet L. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99: 249-254, 1995.
30. Janakidevi K, Fisher MA, Del Vecchio PJ, Tiruppathi C, Figge J, and Malik AB. Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am J Physiol 263: C1295-C1301, 1992.
31. Kim SB, Yang WS, Lee OS, Lee KP, Park JS, and Na DS. Lipocortin-1 inhibits proliferation of cultured human me-sangial cells. Nephron 74: 39-44, 1996.
32. Kitta K, Day RM, Kim Y, Torregroza I, Evans T, and Suzuki YJ. Hepatocyte growth factor induces GATA-4 phosphory-lation and cell survival in cardiac muscle cells. J Biol Chem 278: 4705-4712, 2003.
33. Lawrie A, Spiekerkoetter E, Martinez EC, Ambartsumian N, Sheward WJ, MacLean MR, Harmar AJ, Schmidt AM, Lu-kanidin E, and Rabinovitch M. Interdependent serotonin transporter and receptor pathways regulate S100A4=Mts1, a gene associated with pulmonary vascular disease. Circ Res 97: 227-235, 2005.
34. Lee SL, Wang WW, Moore BJ, and Fanburg BL. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res 68: 1362-1368, 1991.
35. Lee SL, Wang WW, and Fanburg BL. Superoxide as an intermediate signal for serotonin-induced mitogenesis. Free Rad Biol Med 24: 855-858, 1998.
36. Lee SL, Wang WW, Finlay GA, and Fanburg BL. Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion. Am J Physiol 277: L282-L291, 1999.
37. 2 signals 5-HT-induced ERK MAP kinase activation and mito-genesis of smooth muscle cells. Am J Physiol 281: L646-L652, 2001.
38. Levine RL. Proteolysis induced by metal-catalyzed oxidation. Revis Biol Celular 21: 347-360, 1989.
39. Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 32: 790-796, 2002.
40. Levine RL, Oliver CN, Fulks RM, and Stadtman ER. Turnover of bacterial glutamine synthetase: Oxidative inac-tivation precedes proteolysis. Proc Natl Acad Sci USA 78: 2120-2124, 1981.
41. Levine RL, Williams JA, Stadtman ER, and Shacter E. Car-bonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233: 346-357, 1994.
42. Levine RL, Wehr N, Williams JA, Stadtman ER, and Shacter E. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol 99: 15-24, 2000.
43. Liu Y, Suzuki YJ, Day RM, and Fanburg BL. Rho kinase-induced nuclear translocation of ERK1=ERK2 in smooth muscle cell mitogenesis caused by serotonin. Circ Res 95: 579-586, 2004.
44. Liu L, Marcocci L, Wong CM, Park A, and Suzuki YJ. Serotonin-mediated protein carbonylation in the right heart. Free Radic Biol Med 45: 847-854, 2008.
45. MacLean MR, Deuchar GA, Hicks MN, Morecroft I, Shen S, Sheward J, Colston J, Loughlin L, Nilsen M, Dempsie Y, and Harmar A. Overexpression of the 5-hydroxytryptamine transporter gene: Effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension. Circulation 109: 2150-2155, 2004.
46. May JM, and de Haën C. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J Biol Chem 254: 2214-2220, 1979.
47. McCord JM and Fridovich I. Superoxide dismutase. An en-zymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055, 1969.
48. Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, and Goto K. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 73: 887-897, 1993.
49. Moran LK, Gutteridge JM, and Quinlan GJ. Thiols in cellular redox signalling and control. Curr Med Chem 8: 763-772, 2001.
50. Park A., L. Liu, C. Wong and Y. J. Suzuki. Pulmonary hypertension activates GATA-4 in the right heart: Role of CBF=NF-Y in the regulation of Gata4 gene transcription. Am J Resp Crit Care Med 179: A4140, 2009 (Abstract)
51. Perez-Reyes E, and Mason RP. Characterization of the structure and reactions of fee radicals from serotonin and related indoles. J Biol Chem 256: 2427-2432, 1981.
52. Rao GN and Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70: 593-599, 1992.
53. Roederer M, Staal FJ, Raju PA, Ela SW, Herzenberg LA, and Herzenberg LA. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci USA 87: 4884-4888, 1990.
54. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, and Simonneau G. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346: 896-903, 2002. (Pubitemid 34984638)
55. Runo JR and Loyd JE. Primary pulmonary hypertension. Lancet 361: 1533-1544, 2003.
56. Sato K, Webb S, Tucker A, Rabinovitch M, Obrien RF, McMurtry IF, and Stelzne TJ. Factors influencing the idio-pathic development of pulmonary hypertension in the Fawn-Hooded rat. Am Rev Respir Dis 145: 793-797, 1992.
57. Sayre LM, Lin D, Yuan Q, Zhu X, and Tang X. Protein ad-ducts generated from products of lipid oxidation: Focus on HNE and one. Drug Metab Rev 38: 651-675, 2006.
58. Schreck R, Rieber P, and Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
59. Sen CK. Cellular thiols and redox-regulated signal trans-duction. Curr Top Cell Regul 36: 1-30, 2000.
60. Shacter E, Williams JA, Lim M, and Levine RL. Differential susceptibility of plasma proteins to oxidative modification: Examination by Western blot immunoassay. Free Radic Biol Med 17: 429-437, 1994.
61. Siems WG, Hapner SJ, and van Kuijk FJ. 4-Hydroxynonenal inhibits Na(+)-K(+)-ATPase. Free Radic Biol Med 20: 215-223, 1996.
62. Solito E, de Coupade C, Canaider S, Goulding NJ, and Perretti M. Transfection and annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated ap-optosis associated with caspase-3 activation. Br J Pharmacol 133: 217-228, 2001.
63. Staal FJ, Roederer M, Herzenberg LA, and Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 87: 9943-9947, 1990.
64. Stadtman ER and Levine RL. Protein oxidation. Ann NY Acad Sci 899: 191-208, 2000.
65. Stewart DJ, Levy RD, Cernacek P, and Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: Marker for mediator of disease? Ann Intern Med 114: 464-469, 1991.
66. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
67. 2+ release from vascular smooth muscle sarcoplasmic re-ticulum. Am J Physiol 262: H114-H116, 1992.
68. Suzuki YJ and Ford GD. Mathematical model supporting the superoxide theory of oxygen toxicity. Free Radic Biol Med 16: 63-72, 1994.
69. Suzuki YJ, Forman HJ, and Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 22: 269-285, 1997.
70. Suzuki YJ, Day RM, Tan CC, Sandven TH, Liang Q, Molk-entin JD, and Fanburg BL. Activation of GATA-4 by serotonin in pulmonary artery smooth muscle cells. J Biol Chem 278: 17525-17531, 2003.
71. phox is a critical component of the superoxide-generating NADH=NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271: 23317-23321, 1996.
72. Veal EA, Day AM, and Morgan BA. Hydrogen peroxide sensing and signaling. Mol Cell 26: 1-14, 2007.
73. Walther DJ, Peter JU, Winter S, Höltje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, and Bader M. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115: 851-862, 2003.
74. Wedgwood S, Dettman RW, and Black SM. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol 281: L1058-L1067, 2001.
75. Wedgwood S and Black SM. Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension. Antioxid Redox Signal 5: 759-769, 2003.
76. Wong CM and Suzuki YJ. Chronic hypoxia increases car-bonylated proteins in rat pulmonary artery. Proc Am Thorac Soc 3: A173, 2006 (Abstract).
77. Wong CM and Suzuki YJ. Serotonin promotes redox signaling via protein carbonylation in pulmonary artery smooth muscle. Am J Resp Crit Care Med 175: A41, 2007 (Abstract).
78. Wong CM, Cheema AK, Zhang L, and Suzuki YJ. Protein carbonylation as a novel mechanism in redox signaling. Circ Res 102: 310-318, 2008.
79. Wong C and Suzuki YJ. Protein carbonylation signaling in pulmonary hypertension. Am J Resp Crit Care Med 179: A2482, 2009 (Abstract).
80. Zamora MR, Stelzner TJ, Webb S, Panos RJ, Ruff LJ, and Dempsey EC. Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats. Am J Physiol 270: L101-L109, 1996.